相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan
James L. Januzzi et al.
CIRCULATION-HEART FAILURE (2020)
Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
Nasrien E. Ibrahim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome A Secondary Analysis of the VISTA-16 Trial
Preethi Mani et al.
JAMA CARDIOLOGY (2019)
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction
James L. Januzzi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Functional Screening Identifies MicroRNA Regulators of Corin Activity and Atrial Natriuretic Peptide Biogenesis
Selvi Celik et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP
Shawn H. Reginauld et al.
JACC-HEART FAILURE (2019)
Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study
Helene Nougue et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Antisense regulation of atrial natriuretic peptide expression
Seivi Celik et al.
JCI INSIGHT (2019)
Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
James L. Januzzi et al.
AMERICAN HEART JOURNAL (2018)
Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
Emilia D'Elia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease Results From the EXCEL Trial
Suzanne J. Baron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure
Laura C. van Vark et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
Jens Buttgereit et al.
CARDIOVASCULAR RESEARCH (2016)
Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
Zhanna Kobalava et al.
CARDIOVASCULAR THERAPEUTICS (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
M-Atrial Natriuretic Peptide: A Novel Antihypertensive Protein Therapy
Paul M. McKie et al.
CURRENT HYPERTENSION REPORTS (2012)
A Novel Atrial Natriuretic Peptide Based Therapeutic in Experimental Angiotensin II Mediated Acute Hypertension
Paul M. McKie et al.
HYPERTENSION (2010)
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction
T Socki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: Interference between CNP and endothelin-1 signaling pathways
T Tokudome et al.
ENDOCRINOLOGY (2004)
Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts
T Horio et al.
ENDOCRINOLOGY (2003)
分享论文
